LTC Properties vs National Health Investors
LTC and NHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LTC and NHI compare
National Health Investors is the larger company, worth 1.4 times as much as LTC Properties ($3.3B against $2.4B).
On earnings, LTC Properties is cheaper: it trades at 16.4× trailing earnings, against 19.4× for National Health Investors.
LTC Properties grew revenue faster over the last twelve months (59.8% versus 23.9% for National Health Investors).
LTC Properties keeps more of each dollar of sales as profit, with a net margin of 38.9% compared with 38.6% at National Health Investors.
Both pay dividends: LTC Properties yields 4.7% and National Health Investors 5.5%.
LTC Properties scores higher on the StockData Score (19 against 14 for National Health Investors), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LTC | NHI |
|---|---|---|
| Size and price | ||
| Market cap | $2.4B | $3.3B |
| Share price | $44.75 | $67.04 |
| Change, 1 year | 29.2% | −8.9% |
| Change, 5 years | 32.3% | 20.9% |
| Beta (5Y) | 0.42 | 0.38 |
| Employees | 25 | 32 |
| StockData Score | ||
| Total score | 19 (better) | 14 |
| Valuation score | 3 | 3 |
| Growth score | 3 | 5 (better) |
| Performance score | 4 (better) | 3 |
| Health score | 4 (better) | 0 |
| Dividend score | 5 (better) | 3 |
| Valuation | ||
| P/E | 16.4× (better) | 19.4× |
| P/S | 6.9× (better) | 7.6× |
| P/B | 1.9× (better) | 2.1× |
| EV/EBITDA | 9.3× | – |
| PEG | 30.65 | 0.72 (better) |
| Fair value | $46.81 | $69.56 |
| Margin of safety | 4.4% (better) | 3.6% |
| Growth | ||
| Revenue growth (TTM) | 59.8% (better) | 23.9% |
| Revenue growth, 5Y average | 10.5% (better) | 2.5% |
| Net income growth (TTM) | 62.7% (better) | 16.7% |
| EPS growth (TTM) | 50.0% (better) | 10.5% |
| EPS growth, 5Y average | 0.81% (better) | −6.1% |
| Profitability | ||
| Operating margin | 62.6% | – |
| Net margin | 38.9% (better) | 38.6% |
| Return on equity | 12.2% (better) | 10.9% |
| Return on invested capital | 19.8% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Altman Z-score | 2.22 | 2.93 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 4.7% | 5.5% (better) |
| Payout ratio | 83.3% | 105% |
| Years of dividend growth | 0 | 1 (better) |
| Dividend growth, 5Y average | 0.00% (better) | −4.6% |
| Buyback yield | −11.8% | −3.1% (better) |
| Shareholder yield | −7.1% | 2.4% (better) |
| Ownership | ||
| Held by institutions | 79.7% | 77.7% |
| Held by insiders | 2.2% | 2.5% |
| Insider net buying, 12 months | $1.3M (better) | $167K |
| Short interest, % of float | 6.2% | 5.0% |
Go deeper
- LTC stock overview
- LTC income statement
- LTC valuation and score
- NHI stock overview
- NHI income statement
- NHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.